AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...
A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...
The mailman parked in front of my house today and asked for me. I had no clue what it was all about. He had two packages from Hong Kong, and I just assumed my wife had ordered something as a surprise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results